SWX:NOVN Earnings and Revenue History May 6th 2025 The Impact Of Unusual Items On Profit. For anyone who wants to understand ...

Novartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 ...

A Delaware district court must maintain its pause of an order that the FDA delay final approval of MSN Laboratories Pvt. Ltd.

The first-quarter results for Novartis AG ( VTX:NOVN ) were released last week, making it a good time to revisit ...

Germany: BioNTech SE has announced that the Supervisory Board has appointed Ramon Zapata-Gomez to the Management Board as ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Novartis raises 2025 sales and profit forecast as key drugs drive strong Q1 results; core operating income up 23% to $5.6 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...